{
  "abstract": "The intersection of tuberculosis (TB) and diabetes mellitus (DM) represents a pressing global health concern that demands urgent attention. DM is a well-established risk factor for TB, increasing susceptibility to the disease and worsening treatment outcomes.1–3 Compounding this, TB patients with uncontrolled hyperglycaemia—whether due to pre-existing DM or TB-induced stress hyperglycaemia—face a higher risk of poor TB outcomes.4–6 In response, the WHO has recommended diabetes screening for TB patients since 2011.7",
  "authors": [
    {
      "affiliations": [
        "Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts, USA",
        "Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA"
      ],
      "name": "Chuan-Chin Huang"
    },
    {
      "affiliations": [
        "Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts, USA",
        "Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA"
      ],
      "name": "Megan B Murray"
    }
  ],
  "title": "Tuberculous hyperglycaemia: a clinical, epidemiological and public health perspective",
  "uid": "c1dc39ab-61a5-5e4e-8dda-f3511521649c"
}